Eculizumab in Pediatric and Adult Participants With Atypical Hemolytic Uremic Syndrome (aHUS) in China
Condition(s):Atypical Hemolytic UremicLast Updated:February 21, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Atypical Hemolytic UremicLast Updated:February 21, 2024Recruiting
Condition(s):Healthy SubjectsLast Updated:May 15, 2020Completed
Condition(s):Paroxysmal Nocturnal HemoglobinuriaLast Updated:January 5, 2024Active, not recruiting
Condition(s):HealthyLast Updated:November 24, 2023Recruiting
Condition(s):Covid19Last Updated:October 4, 2021No longer available
Condition(s):Paroxysmal Nocturnal Hemoglobinuria; Marchiafava-Micheli Syndrome; Paroxysmal HemoglobinuriaLast Updated:September 1, 2021Completed
Condition(s):Neuromyelitis Optica; Neuromyelitis Optica Spectrum DisorderLast Updated:October 16, 2023Active, not recruiting
Condition(s):COVID-19; Pneumonia, Viral; Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)Last Updated:March 9, 2021No longer available
Condition(s):Paroxysmal Nocturnal HemoglobinuriaLast Updated:February 2, 2024Not yet recruiting
Condition(s):Guillain-Barre SyndromeLast Updated:February 9, 2024Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.